Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, et al
The dual activation in Tirzepatide produces roughly 21% weight loss
GLP-1/GIP/GCG Triple Agonists The most researched combination of receptors targeted with triple agonists are GLP-1/GIP/GCG
N/A, not applicable
A: The best foods that help digestion are those that are bland, easy to process, and nutrient-dense
if pancreatitis is suspected, do not take any further doses and seek urgent medical assessment immediately [15] [16] Pain in the upper right abdomen, or yellowing of the skin or whites of the eyes (jaundice) these may indicate gallbladder disease, a risk associated with rapid weight loss and GLP-1 receptor agonist use [16] [17] Fever accompanying diarrhoea, which may suggest an infective cause requiring separate investigation Significant unintentional weight loss beyond what is expected from the treatment For people with type 2 diabetes: persistent diarrhoea can reduce carbohydrate absorption and increase the risk of hypoglycaemia, particularly if insulin or sulphonylureas are co-prescribed
